485 related articles for article (PubMed ID: 34529725)
1. A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
Kim SS; Hudgins AD; Yang J; Zhu Y; Tu Z; Rosenfeld MG; DiLorenzo TP; Suh Y
PLoS One; 2021; 16(9):e0257265. PubMed ID: 34529725
[TBL] [Abstract][Full Text] [Related]
2. Disease-specific biases in alternative splicing and tissue-specific dysregulation revealed by multitissue profiling of lymphocyte gene expression in type 1 diabetes.
Newman JRB; Conesa A; Mika M; New FN; Onengut-Gumuscu S; Atkinson MA; Rich SS; McIntyre LM; Concannon P
Genome Res; 2017 Nov; 27(11):1807-1815. PubMed ID: 29025893
[TBL] [Abstract][Full Text] [Related]
3. Risk variants disrupting enhancers of T
Gao P; Uzun Y; He B; Salamati SE; Coffey JKM; Tsalikian E; Tan K
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7581-7590. PubMed ID: 30910956
[TBL] [Abstract][Full Text] [Related]
4. An integrative functional genomics framework for effective identification of novel regulatory variants in genome-phenome studies.
Zhao J; Cheng F; Jia P; Cox N; Denny JC; Zhao Z
Genome Med; 2018 Jan; 10(1):7. PubMed ID: 29378629
[TBL] [Abstract][Full Text] [Related]
5. Systematic Evaluation of Genes and Genetic Variants Associated with Type 1 Diabetes Susceptibility.
Ram R; Mehta M; Nguyen QT; Larma I; Boehm BO; Pociot F; Concannon P; Morahan G
J Immunol; 2016 Apr; 196(7):3043-53. PubMed ID: 26912320
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.
Selvarajan I; Toropainen A; Garske KM; López Rodríguez M; Ko A; Miao Z; Kaminska D; Õunap K; Örd T; Ravindran A; Liu OH; Moreau PR; Jawahar Deen A; Männistö V; Pan C; Levonen AL; Lusis AJ; Heikkinen S; Romanoski CE; Pihlajamäki J; Pajukanta P; Kaikkonen MU
Am J Hum Genet; 2021 Mar; 108(3):411-430. PubMed ID: 33626337
[TBL] [Abstract][Full Text] [Related]
7. 3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk.
Liu N; Sadlon T; Wong YY; Pederson S; Breen J; Barry SC
Epigenetics Chromatin; 2022 Jun; 15(1):24. PubMed ID: 35773720
[TBL] [Abstract][Full Text] [Related]
8. Effects of GWAS-associated genetic variants on lncRNAs within IBD and T1D candidate loci.
Mirza AH; Kaur S; Brorsson CA; Pociot F
PLoS One; 2014; 9(8):e105723. PubMed ID: 25144376
[TBL] [Abstract][Full Text] [Related]
9. INFERNO: inferring the molecular mechanisms of noncoding genetic variants.
Amlie-Wolf A; Tang M; Mlynarski EE; Kuksa PP; Valladares O; Katanic Z; Tsuang D; Brown CD; Schellenberg GD; Wang LS
Nucleic Acids Res; 2018 Sep; 46(17):8740-8753. PubMed ID: 30113658
[TBL] [Abstract][Full Text] [Related]
10. Biomedical Data Commons (BMDC) prioritizes B-lymphocyte non-coding genetic variants in Type 1 Diabetes.
Piekos SN; Gaddam S; Bhardwaj P; Radhakrishnan P; Guha RV; Oro AE
PLoS Comput Biol; 2021 Sep; 17(9):e1009382. PubMed ID: 34543288
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of genome-wide association studies and 3D epigenomic characteristics reveal the BMP2 gene regulating loin muscle depth in Yorkshire pigs.
Miao Y; Zhao Y; Wan S; Mei Q; Wang H; Fu C; Li X; Zhao S; Xu X; Xiang T
PLoS Genet; 2023 Jun; 19(6):e1010820. PubMed ID: 37339141
[TBL] [Abstract][Full Text] [Related]
12. A genome-wide functional genomics approach uncovers genetic determinants of immune phenotypes in type 1 diabetes.
Chu X; Janssen AWM; Koenen H; Chang L; He X; Joosten I; Stienstra R; Kuijpers Y; Wijmenga C; Xu CJ; Netea MG; Tack CJ; Li Y
Elife; 2022 May; 11():. PubMed ID: 35638288
[TBL] [Abstract][Full Text] [Related]
13. Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes.
Robertson CC; Inshaw JRJ; Onengut-Gumuscu S; Chen WM; Santa Cruz DF; Yang H; Cutler AJ; Crouch DJM; Farber E; Bridges SL; Edberg JC; Kimberly RP; Buckner JH; Deloukas P; Divers J; Dabelea D; Lawrence JM; Marcovina S; Shah AS; Greenbaum CJ; Atkinson MA; Gregersen PK; Oksenberg JR; Pociot F; Rewers MJ; Steck AK; Dunger DB; ; Wicker LS; Concannon P; Todd JA; Rich SS
Nat Genet; 2021 Jul; 53(7):962-971. PubMed ID: 34127860
[TBL] [Abstract][Full Text] [Related]
14. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers.
Onengut-Gumuscu S; Chen WM; Burren O; Cooper NJ; Quinlan AR; Mychaleckyj JC; Farber E; Bonnie JK; Szpak M; Schofield E; Achuthan P; Guo H; Fortune MD; Stevens H; Walker NM; Ward LD; Kundaje A; Kellis M; Daly MJ; Barrett JC; Cooper JD; Deloukas P; ; Todd JA; Wallace C; Concannon P; Rich SS
Nat Genet; 2015 Apr; 47(4):381-6. PubMed ID: 25751624
[TBL] [Abstract][Full Text] [Related]
15. Enhancer variants associated with Alzheimer's disease affect gene expression via chromatin looping.
Kikuchi M; Hara N; Hasegawa M; Miyashita A; Kuwano R; Ikeuchi T; Nakaya A
BMC Med Genomics; 2019 Sep; 12(1):128. PubMed ID: 31500627
[TBL] [Abstract][Full Text] [Related]
16. Joint Bayesian inference of risk variants and tissue-specific epigenomic enrichments across multiple complex human diseases.
Li Y; Kellis M
Nucleic Acids Res; 2016 Oct; 44(18):e144. PubMed ID: 27407109
[TBL] [Abstract][Full Text] [Related]
17. Integrative genomic deconvolution of rheumatoid arthritis GWAS loci into gene and cell type associations.
Walsh AM; Whitaker JW; Huang CC; Cherkas Y; Lamberth SL; Brodmerkel C; Curran ME; Dobrin R
Genome Biol; 2016 Apr; 17():79. PubMed ID: 27140173
[TBL] [Abstract][Full Text] [Related]
18. The genetic architecture of type 1 diabetes mellitus.
Nyaga DM; Vickers MH; Jefferies C; Perry JK; O'Sullivan JM
Mol Cell Endocrinol; 2018 Dec; 477():70-80. PubMed ID: 29913182
[TBL] [Abstract][Full Text] [Related]
19. Integrative Genomics Analysis Identifies ACVR1B as a Candidate Causal Gene of Emphysema Distribution.
Boueiz A; Pham B; Chase R; Lamb A; Lee S; Naing ZZC; Cho MH; Parker MM; Sakornsakolpat P; Hersh CP; Crapo JD; Stergachis AB; Tal-Singer R; DeMeo DL; Silverman EK; Zhou X; Castaldi PJ;
Am J Respir Cell Mol Biol; 2019 Apr; 60(4):388-398. PubMed ID: 30335480
[TBL] [Abstract][Full Text] [Related]
20. Untangling the genetic link between type 1 and type 2 diabetes using functional genomics.
Nyaga DM; Vickers MH; Jefferies C; Fadason T; O'Sullivan JM
Sci Rep; 2021 Jul; 11(1):13871. PubMed ID: 34230558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
